Storage: standard 28C short-term, -20C long-term, protected from light and moisture
MECHANISM CATEGORIES SAFETY Side effects GI: nausea, vomiting (titration-dependent) Injection-site reactions Hypoglycemia risk when combined with insulin Known interactions Insulin additive hypoglycemia risk Contraindications History of MTC or MEN2 (theoretical class effect) REGULATORY STATUS FDA Not yet FDA-approved as of 2026-05
Gut-immune axis and inflammation The gut-immune axis is another area where BPC 157 could play a significant role
Data Availability The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request
Throughout all of this work, the guiding principle remains the same: BPC-157 10mg and its related products are sold for research purposes only, and every experiment should respect that boundary while contributing carefully collected data to the growing body of preclinical knowledge
In contrast, the no loading dose regimen resulted in a gradual increase, reaching a median vitamin B12 concentration of 717 pmol/L after 90 days